Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/1999
12/08/1999EP0843554B1 Ascorbyl-phosphoryl-cholesterol
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0758879B1 Improved anti-dandruff shampoo
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999EP0660718B1 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
12/08/1999CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999CN1237900A Liquid personal cleansing compositions which contain encapsulated lipophilic skin moisturizing agent comprised of relatively large droplets
12/08/1999CN1237899A Skin care compositions containing amide and retinoid
12/08/1999CN1237898A Skin care composition containing amide and retinol or retinyl ester
12/08/1999CN1237897A Skin care compositions containing acid and retinoid
12/08/1999CN1237896A Cosmetic preparation with peptide addition
12/08/1999CN1237895A Cosmetic cleansing and skin care preparation containing plant and algae extracts
12/08/1999CN1237437A Chinese medicine composition for producing domestic chemical product
12/08/1999CN1237426A Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998480 Pharmaceutical preparation containing nimesulide for topical use
12/07/1999US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999US5998423 Methods for modulating melanin production
12/07/1999US5998395 Methods of treating inflammatory dermatosis
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999US5998364 Component B as cicatrizant
12/07/1999US5997893 Alcohol based anti-microbial compositions with cosmetic appearance
12/07/1999US5997885 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging
12/07/1999US5997876 Burn and wound ointment
12/07/1999US5997875 Herbal composition and treatment methods
12/07/1999US5997874 Dihydrophenanthrene
12/07/1999US5997863 Attenuation of wound healing processes
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2005846C Skin treatment method
12/02/1999WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999WO1999061041A1 Novel peptides
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060997A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
12/02/1999WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999EP0960618A2 Compositions of clindamycin and benzoyl peroxide for acne treatment
12/01/1999EP0960572A1 Nutritional composition for the treatment of pressure ulcers
12/01/1999EP0960192A1 Synthetic polynucleotides
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960098A1 Arylsulfonyl hydroxamic acid derivatives
12/01/1999EP0959889A1 Methods and compositions to inhibit keratinocyte proliferation
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999CN1237177A Fused bicyclic pyrimidine derivatives
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237151A Method for treatment of dermatological disorders
12/01/1999CN1236671A Catalyst composition
12/01/1999CN1236633A Powdered medicine for treating beriberi
12/01/1999CN1236622A Medicine for treating intractable ulcer and its preparing process
12/01/1999CN1236610A Chinese medicine for protecting skin
12/01/1999CN1046942C Imidazopyridines
12/01/1999CN1046939C Fluoroalkoxy-substituted benzamides and their preparing process and use
12/01/1999CN1046929C Process for isomerizing linear olefins to isoolefins
11/1999
11/30/1999US5994376 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
11/30/1999US5994367 Method for treating tumors using 2-aryl-naphthyridin-4-ones
11/30/1999US5994344 Bronchitis therapy
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994326 Using raffinose
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994319 Synergistic mixture
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994096 Regulator
11/30/1999US5993859 Pharmaceutical agents
11/30/1999US5993845 Histone deacetylase inhibitor and a pharmaceutically acceptable carrier wherein the composition comprises from 0.05 to 100 mg of the histone deacetylase inhibitor.
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/30/1999US5993833 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition
11/30/1999US5993830 Combining a fatty acid, triethanolamine, propylene glycol, polyvinylpyrrolidone, polydimethylsiloxane, and either glycerol, sorbitol or polyethylene glycol
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993788 Polysaccharide alkyl ether. protecting skin and hair against damaging effects of ultraviolet radiation.
11/30/1999US5993787 Composition base for topical therapeutic and cosmetic preparations
11/30/1999CA1340834C Derivatives of human/bovine basic fibroblast growth factor
11/26/1999CA2272840A1 Association of a retinoid with a histidine derivative
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1065